Matrisys Bioscience

MatriSys Bioscience is leading the discovery and clinical development of a new class of biopharmaceuticals to transform the treatment of inflammatory skin diseases. Our breakthrough technology platform identifies beneficial bacteria from healthy human skin for the treatment of millions of children and adults suffering from difficult-to-treat chronic skin conditions. Alongside our leading clinical program in patients with atopic dermatitis, we are also rapidly advancing treatments for acne and rosacea.